Key Insights
The North America pharmaceutical plastic packaging market, valued at $16.51 billion in 2025, is projected to experience robust growth, driven by several key factors. The increasing demand for pharmaceutical products, coupled with the rising preference for convenient and tamper-evident packaging solutions, fuels market expansion. Advances in plastic materials technology, offering improved barrier properties, extended shelf life, and enhanced patient safety features, further contribute to market growth. The pharmaceutical industry's growing focus on reducing carbon footprint and adopting sustainable packaging practices is also influencing market dynamics, with a shift towards recyclable and biodegradable materials gaining traction. This trend is expected to lead to innovations in packaging design and material selection, stimulating market growth. However, regulatory hurdles related to material safety and environmental concerns could present challenges to the market's trajectory. Stringent regulations on plastic waste disposal and the increasing cost of raw materials also represent potential restraints. Despite these challenges, the market is anticipated to maintain a healthy Compound Annual Growth Rate (CAGR) of 5.97% from 2025 to 2033. This growth will be fueled by continuous innovation in packaging designs and materials, catering to the diverse needs of the pharmaceutical industry. Competition among established players like Gerresheimer AG, Amcor, and Berry Global, alongside emerging companies, will shape the market landscape in the coming years.
North America Pharmaceutical Plastic Packaging Market Market Size (In Billion)
The market segmentation within North America likely reflects a diverse range of pharmaceutical packaging types, including bottles, vials, blister packs, and pouches, each with its own growth trajectory influenced by specific product requirements and consumer preferences. Regional variations within North America may also exist, reflecting differences in healthcare infrastructure, regulatory environments, and market demands across different states and regions. Future market projections should consider these segment-specific trends and regional variations to provide a comprehensive understanding of the North American pharmaceutical plastic packaging market's future. The ongoing development of innovative packaging solutions, tailored to specific drug delivery systems and patient needs, will continue to be a key driver of growth, promising considerable opportunities for market players in the years to come.
North America Pharmaceutical Plastic Packaging Market Company Market Share
North America Pharmaceutical Plastic Packaging Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the North America pharmaceutical plastic packaging market, offering valuable insights for industry stakeholders, investors, and strategic decision-makers. The study period spans 2019-2033, with 2025 serving as the base and estimated year. The report meticulously examines market dynamics, growth drivers, challenges, and emerging opportunities, providing a detailed forecast for 2025-2033. The report leverages a robust data-driven approach, incorporating historical data (2019-2024) to inform the projections.
North America Pharmaceutical Plastic Packaging Market Concentration & Innovation
This section analyzes the competitive landscape of the North American pharmaceutical plastic packaging market, examining market concentration, innovation drivers, regulatory frameworks, product substitutes, end-user trends, and mergers and acquisitions (M&A) activities.
The market exhibits a moderately concentrated structure, with several major players holding significant market share. Precise market share data for individual companies is proprietary information within the full report. However, key players such as Gerresheimer AG, Amcor Group GmbH, and Berry Global Group Inc. are significantly impacting market dynamics due to their scale and innovative capabilities. The overall market value is estimated at xx Million in 2025, with a projected CAGR of xx% during the forecast period.
Key aspects analyzed:
- Market Concentration: Assessment of the Herfindahl-Hirschman Index (HHI) to quantify market concentration.
- Innovation Drivers: Analysis of factors driving innovation, including sustainability concerns, regulatory pressures, and evolving consumer preferences.
- Regulatory Frameworks: Examination of FDA regulations and other relevant standards impacting the market.
- Product Substitutes: Evaluation of alternative packaging materials and their potential impact on market share.
- End-User Trends: Analysis of changing pharmaceutical packaging preferences across various segments (e.g., hospitals, pharmacies, and consumers).
- M&A Activities: Review of recent significant mergers and acquisitions, including their impact on market consolidation and competitive dynamics. The total value of M&A deals within the past five years is estimated to be xx Million.
North America Pharmaceutical Plastic Packaging Market Industry Trends & Insights
This section delves into the key trends shaping the North American pharmaceutical plastic packaging market, providing a detailed overview of growth drivers, technological advancements, consumer preferences, and competitive dynamics. The market is witnessing substantial growth fueled by several factors, including the increasing demand for pharmaceutical products, the growing preference for convenient and tamper-evident packaging, and a rising focus on sustainable and eco-friendly packaging solutions.
The market is experiencing significant technological disruptions, with the adoption of advanced technologies such as smart packaging and connected packaging solutions transforming the industry. Consumer preferences are increasingly shifting towards sustainable and recyclable packaging options, putting pressure on manufacturers to adopt eco-friendly materials and production processes. The competitive landscape is characterized by intense competition among established players and emerging companies, leading to continuous innovation and product differentiation.
Key Metrics:
- CAGR: The Compound Annual Growth Rate (CAGR) for the market during the forecast period is projected at xx%.
- Market Penetration: Analysis of the penetration of various packaging types (e.g., blister packs, bottles, and pouches) across different segments.
Dominant Markets & Segments in North America Pharmaceutical Plastic Packaging Market
This section identifies the leading regions, countries, and segments within the North American pharmaceutical plastic packaging market, providing a detailed analysis of their dominance. The United States represents the largest market segment, driven by factors such as a large pharmaceutical industry, robust healthcare infrastructure, and high consumer spending on healthcare products.
Key Drivers of Market Dominance:
United States:
- Large pharmaceutical industry and high healthcare expenditure.
- Well-established infrastructure for packaging manufacturing and distribution.
- Favorable regulatory environment promoting innovation and growth.
Canada:
- Growing pharmaceutical market fueled by an aging population.
- Increasing investments in healthcare infrastructure and technology.
- Government initiatives promoting the adoption of sustainable packaging solutions.
Mexico:
- Expanding pharmaceutical industry fueled by growing demand for affordable healthcare.
- Increasing investments in manufacturing and infrastructure.
- Opportunities for growth in the generic pharmaceutical packaging segment.
North America Pharmaceutical Plastic Packaging Market Product Developments
The pharmaceutical plastic packaging market is witnessing continuous product innovation, with a focus on developing sustainable, tamper-evident, and patient-friendly packaging solutions. Recent advancements include the introduction of recyclable blister packs made from HDPE, lightweight tube closures using recycled plastics, and smart packaging incorporating RFID technology for tracking and authentication. These innovations are enhancing product safety, improving supply chain efficiency, and promoting sustainability. The market is seeing a clear trend toward using recycled and bio-based materials.
Report Scope & Segmentation Analysis
This report segments the North America pharmaceutical plastic packaging market based on several key factors, including material type (e.g., HDPE, PP, PET, PVC), packaging type (e.g., blister packs, bottles, tubes, pouches), application (e.g., solid dosage forms, liquid dosage forms, injectables), and end-user (e.g., hospitals, pharmacies, clinics). Each segment’s market size, growth projection, and competitive landscape are analyzed in detail. For example, the HDPE segment is expected to experience significant growth due to its recyclability and cost-effectiveness. The blister pack segment is expected to maintain a large share due to its widespread use in protecting tablets and capsules.
Key Drivers of North America Pharmaceutical Plastic Packaging Market Growth
The North American pharmaceutical plastic packaging market's growth is propelled by several key factors. The rising demand for pharmaceutical products, driven by an aging population and increasing prevalence of chronic diseases, is a major driver. Furthermore, the growing need for tamper-evident and child-resistant packaging, driven by stringent regulations and increasing consumer awareness of product safety, is significantly impacting market growth. Technological advancements, particularly in sustainable and smart packaging solutions, are also contributing to market expansion. Finally, increasing government regulations promoting the use of sustainable packaging materials are fostering market growth.
Challenges in the North America Pharmaceutical Plastic Packaging Market Sector
The North America pharmaceutical plastic packaging market faces several challenges, including stringent regulatory requirements impacting product development and approval processes, and fluctuating raw material prices affecting profitability. Supply chain disruptions due to geopolitical events or natural disasters can also impact market stability. The intense competition among established players and emerging companies necessitates ongoing innovation and cost optimization to maintain market share and profitability. The increasing focus on sustainability adds pressure on companies to adopt environmentally friendly materials and practices.
Emerging Opportunities in North America Pharmaceutical Plastic Packaging Market
The North American pharmaceutical plastic packaging market presents various opportunities for growth. The increasing adoption of sustainable packaging solutions, such as recycled and bio-based materials, creates significant opportunities for companies committed to environmental responsibility. The growing demand for smart packaging solutions, including those incorporating RFID technology or other forms of digital connectivity, offers potential for market expansion. Expansion into niche segments, such as personalized medicine packaging, also presents lucrative opportunities for market players.
Leading Players in the North America Pharmaceutical Plastic Packaging Market Market
- Gerresheimer AG
- Amcor Group GmbH
- Berry Global Group Inc
- Comar LLC
- Klockner Pentaplast Group
- Nipro Medical Corporation
- James Alexander Corporation
- Drug Plastics Group
- Pretium Packaging
- Bormioli Pharma United States Inc (Bormioli Pharma S p A )
- Silgan Plastics (Silgan Holdings Inc) *List Not Exhaustive
Key Developments in North America Pharmaceutical Plastic Packaging Market Industry
July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. This launch signifies a significant shift towards sustainable packaging within the pharmaceutical industry.
April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution made from virgin or recycled plastics. This demonstrates a commitment to reducing environmental impact while maintaining product functionality.
Strategic Outlook for North America Pharmaceutical Plastic Packaging Market Market
The North America pharmaceutical plastic packaging market is poised for sustained growth, driven by continuous innovation in sustainable materials, smart packaging technologies, and a rising focus on patient convenience. Companies investing in research and development of eco-friendly solutions and digital capabilities will be well-positioned to capitalize on emerging opportunities. The market’s future success hinges on adapting to evolving regulations, maintaining supply chain resilience, and meeting consumer demand for safe, convenient, and sustainable packaging solutions.
North America Pharmaceutical Plastic Packaging Market Segmentation
-
1. Raw Material
- 1.1. Polypropylene (PP)
- 1.2. Polyethylene Terephthalate (PET)
- 1.3. Low Density Polyethylene (LDPE)
- 1.4. High Density Polyethylene (HDPE)
- 1.5. Other Raw Materials
-
2. Product Type**
- 2.1. Solid Containers
- 2.2. Dropper Bottles
- 2.3. Nasal Spray Bottles
- 2.4. Liquid Bottles
- 2.5. Oral Care
- 2.6. Pouches
- 2.7. Vials and Ampoules
- 2.8. Cartridges
- 2.9. Syringes
- 2.10. Caps and Closure
- 2.11. Other Product Types
North America Pharmaceutical Plastic Packaging Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
North America Pharmaceutical Plastic Packaging Market Regional Market Share
Geographic Coverage of North America Pharmaceutical Plastic Packaging Market
North America Pharmaceutical Plastic Packaging Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.97% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.3. Market Restrains
- 3.3.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.4. Market Trends
- 3.4.1. Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Pharmaceutical Plastic Packaging Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 5.1.1. Polypropylene (PP)
- 5.1.2. Polyethylene Terephthalate (PET)
- 5.1.3. Low Density Polyethylene (LDPE)
- 5.1.4. High Density Polyethylene (HDPE)
- 5.1.5. Other Raw Materials
- 5.2. Market Analysis, Insights and Forecast - by Product Type**
- 5.2.1. Solid Containers
- 5.2.2. Dropper Bottles
- 5.2.3. Nasal Spray Bottles
- 5.2.4. Liquid Bottles
- 5.2.5. Oral Care
- 5.2.6. Pouches
- 5.2.7. Vials and Ampoules
- 5.2.8. Cartridges
- 5.2.9. Syringes
- 5.2.10. Caps and Closure
- 5.2.11. Other Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- 6.2. Company Profiles
- 6.2.1 Gerresheimer AG
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Amcor Group GmbH
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Berry Global Group Inc
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Comar LLC
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Klockner Pentaplast Group
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Nipro Medical Corporation
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 James Alexander Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Drug Plastics Group
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Pretium Packaging
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Bormioli Pharma United States Inc (Bormioli Pharma S p A )
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.1 Gerresheimer AG
List of Figures
- Figure 1: North America Pharmaceutical Plastic Packaging Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: North America Pharmaceutical Plastic Packaging Market Share (%) by Company 2025
List of Tables
- Table 1: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2020 & 2033
- Table 2: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2020 & 2033
- Table 3: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2020 & 2033
- Table 4: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2020 & 2033
- Table 5: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2020 & 2033
- Table 6: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2020 & 2033
- Table 7: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2020 & 2033
- Table 8: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2020 & 2033
- Table 9: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2020 & 2033
- Table 10: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2020 & 2033
- Table 11: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Country 2020 & 2033
- Table 12: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Country 2020 & 2033
- Table 13: United States North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 14: United States North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033
- Table 15: Canada North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 16: Canada North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033
- Table 17: Mexico North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: Mexico North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Pharmaceutical Plastic Packaging Market?
The projected CAGR is approximately 5.97%.
2. Which companies are prominent players in the North America Pharmaceutical Plastic Packaging Market?
Key companies in the market include Gerresheimer AG, Amcor Group GmbH, Berry Global Group Inc, Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, James Alexander Corporation, Drug Plastics Group, Pretium Packaging, Bormioli Pharma United States Inc (Bormioli Pharma S p A ), Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive.
3. What are the main segments of the North America Pharmaceutical Plastic Packaging Market?
The market segments include Raw Material, Product Type**.
4. Can you provide details about the market size?
The market size is estimated to be USD 16.51 Million as of 2022.
5. What are some drivers contributing to market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
6. What are the notable trends driving market growth?
Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers.
7. Are there any restraints impacting market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
8. Can you provide examples of recent developments in the market?
July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. Disrupting the decades-long, over-the-counter standard drug pack, it uses high-density polyethylene (HDPE). AmPrima is a portfolio of recycle-ready packaging solutions for both solid and liquid content.April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution. This innovative closure, crafted from either virgin polyethylene (PE) and polypropylene (PP) or food-safe post-consumer recycled plastics (rPE and rPP), significantly contributes to reducing greenhouse gas emissions. It is particularly suited for personal care and pharmaceutical applications.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Pharmaceutical Plastic Packaging Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Pharmaceutical Plastic Packaging Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Pharmaceutical Plastic Packaging Market?
To stay informed about further developments, trends, and reports in the North America Pharmaceutical Plastic Packaging Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence